ClinicalTrials.gg
Drug

Cyclobenzaprine clinical trials

Also written Flexeril and AMRIX®.

studies test it
42
open now
5
in phase 3
17
first study started
2003

How each study uses cyclobenzaprine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the cyclobenzaprine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Aug 1977 · FLEXERIL · NDA 017821 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

TNX-102 SL
14
Cyclobenzaprine
10
Low dose cyclobenzaprine sublingual tablets
9
cyclobenzaprine HCl
9
TNX-102 SL 5.6 mg
2

Brand

Flexeril
5
AMRIX®
2

Studies by the year they started

40 studies that test it; most in 2013 (5)

Studies that test cyclobenzaprine, by start year
YearStudies
20031
20061
20091
20103
20111
20121
20135
20141
20154
20162
20173
20183
20193
20201
20224
20252
20264

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
10
Phase 3
17
Phase 4
5
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 30 · Other 12

Tonix Pharmaceuticals, Inc. (24) · Neurana Pharmaceuticals, Inc. (1) · Endeavor Health (1) · Takeda (1) · Montefiore Medical Center (1) · Sandoz (1) · Stony Brook University (1) · University of Alabama at Birmingham (1)

Often tested with

Tested in the same studies.

Oxycodone-acetaminophen (1) · Ibuprofen (1) · Pseudoephedrine (1) · Tamsulosin (1) · Imipramine (1) · Solifenacin (1) · Acetaminophen (1) · Ketorolac (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test cyclobenzaprine, phase 3 first.

Studies

Open first, then newest update. How each study uses cyclobenzaprine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 42

See all 42 studies that test cyclobenzaprine →

Given beside what is tested · 2 — cyclobenzaprine is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with cyclobenzaprine

Codes

What other systems call cyclobenzaprine · ClinicalTrials.gg INT002300

  • MeSH (NLM) C004704cyclobenzaprineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 69O5WQQ5TICYCLOBENZAPRINEConfirmed FDA, NLM, Wikidata
  • RxNorm 21949Confirmed FDA, Wikidata
  • Wikidata Q5198674cyclobenzaprineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C28947CyclobenzaprineOne source FDA
  • DrugBank DB00924One source Wikidata

Also registered as cyclobenzaprine hydrochloride (UNII 0VE05JYS2P · RxNorm 52101).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.